Durvalumab (Recombinant) Formulation (500 Mg, 10 Ml/Bottle) 90 Bottles

国立大学法人 Japan has Released a tender for Durvalumab (Recombinant) Formulation (500 Mg, 10 Ml/Bottle) 90 Bottles in Healthcare and Medicine. The tender was released on Aug 05, 2024.

Country - Japan

Summary - Durvalumab (Recombinant) Formulation (500 Mg, 10 Ml/Bottle) 90 Bottles

Deadline - login to view

MT reference number - 90277453

Product classification - Medical equipments, pharmaceuticals and personal care products

Organization Details:

  Address - Japan

  Contact details - 565656565

  Tender notice no. - 76454545

  MT Ref Id - 90277453

  Document Type - Tender Notices

Notice Details and Documents:

Description - Description: Tender announcementThe following is a public competitive bid.August 5, 2024President of Hokkaido University, National University Corporation, Takarakin Kiyohiro◎Procurement agency number: 415 ◎Location number: 011. Procurement detail s⑴ Item classification number: 4⑵ Purchase item and quantity: Durvalumab (recombinant) preparation (500mg, 10ml/bottle) 90 bottles⑶ Characteristics of procurement item: See bidding instructions.⑷ Delivery period: October 1, 2024 to May 31, 2025⑸ Delivery location: Hokkaido University Hospital⑹ Bidding method: The bid amount should be stated as the unit price per bottle. In addition, when determining the successful bid, the successful

Mt Ref Id - 90277453

Deadline - Aug 20, 2024

Share

Similar Tenders :